Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-27

Clinical Trial Update: Topical 10% Povidone-Iodine in Preventing White Spots [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether topical 10% povidone-iodine can prevent white spot lesions and gingivitis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Povidone-iodine topical solution 10% (povidone-iodine)

Snippet

Sponsor: University of Washington | Conditions: White Spot Lesions, Gingival Inflammation and Bleeding | Phase 2 | Status: RECRUITING